Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Cytoprotective mechanism of the novel gastric peptide BPC157 in Gastrointestinal tract and cultured enteric neurons and glial cells
Peripheral effects Via the AMY2 and AMY3 receptors Cagrilintide acts peripherally: Slowing of gastric emptying , stronger than with GLP-1 Suppression of postprandial glucagon , helps control postprandial glycemic spikes Modulation of bone remodeling (via AMY3), a neutral effect, but clinically monitored Synergy with GLP-1 (the mechanistic basis of CagriSema) The main innovation is the complementarity with the GLP-1 pathway : GLP-1 suppresses appetite via the arcuate nucleus of the hypothalamus (POMC neurons, AgRP/NPY inhibition) Amylin suppresses appetite via the area postrema (CGRP-like neurons) Two independent centers, two independent mechanisms
After reconstitution, the peptides will remain stable for up to 30 days
it distributes through your whole system regardless
Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing. Journal of Physiology and Pharmacology
Known for its powerful regenerative effects, BPC-157 supports tissue repair by promoting angiogenesis (the formation of new blood vessels), stimulating collagen production, and reducing inflammationaccelerating the healing of tendons, ligaments, and muscles while enhancing overall recovery
US$ 20.37
US$ 23.43
US$ 25.15
US$ 24.13
US$ 29.33
US$ 20.22
US$ 21.81
US$ 21.55
US$ 23.33
